Takayasu arteritis: Diagnosis, treatment and prognosis

International Reviews of Immunology

Volumn 31, Issue 6, 2012, Pages 462-473

  Wen, Dan ^a   Du, Xin ^a   Ma, Chang Sheng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Diagnosis; Disease activity; Prognosis; Takayasu arteritis; Treatment

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TUMOR NECROSIS FACTOR INHIBITOR;

ANGIOGRAPHY; AORTA ARCH SYNDROME; AUTOIMMUNITY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIAGNOSTIC VALUE; ECHOGRAPHY; ENVIRONMENTAL FACTOR; ETHNICITY; GEOGRAPHIC DISTRIBUTION; GRANULOMATOUS VASCULITIS; HEREDITY; HUMAN; INFLAMMATION; MAGNETIC RESONANCE ANGIOGRAPHY; PATHOGENESIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION; REVIEW; SURVIVAL RATE;

ADRENAL CORTEX HORMONES; ANGIOPLASTY; AORTOGRAPHY; AUTOIMMUNITY; FEMALE; GENE-ENVIRONMENT INTERACTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE ANGIOGRAPHY; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; TAKAYASU ARTERITIS; YOUNG ADULT;

EID: 84870941220     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.3109/08830185.2012.740105     Document Type: Review

References (73)

1. Numano F, Okawara M, Inomata H, Kobayashi Y. Takayasu's arteritis. Lancet. 2000;356(9234): 1023-1025.
2. Arnaud L, Kahn JE, Girszyn N, et al. Takayasu's arteritis: an update on physiopathology. Eur J Intern Med. 2006;17(4):241-246.
3. Rav-Acha M, Plot L, Peled N, Amital H. Coronary involvement in Takayasu's arteritis. Autoimmun Rev. 2007;6(8):566-571.
4. Rathod KR, Deshmukh HL, Garg AI, et al. Spectrum of angiographic fndings in aortoarteritis. Clin Radiol. 2005;60(7):746-755.
5. Gargah T, Harrath MB, Bachrouche H, et al. First case of childhood Takayasu arteritis with renal artery aneurysms. Pediatr Rheumatol Online J. 2010;8:21.
6. Arnaud L, Haroche J, Mathian A, et al. Pathogenesis of Takayasu's arteritis: a 2011 update. Autoimmun Rev. 2011;11(1):61-67.
7. Kallenberg CG, Tadema H. Vasculitis and infections: contribution to the issue of autoimmunity reviews devoted to "Autoimmunity and infection." Autoimmun Rev. 2008;8(1):29-32.
8. Noris M. Pathogenesis of Takayasu's arteritis. J Nephrol. 2001;14(6):506-513.
9. Cooper GS, Miller FW, Pandey JP. Te role of genetic factors in autoimmune disease: implications for environmental research. Environ Health Perspect. 1999;107((Suppl 5)):693-700.
10. Kasuya N, Kishi Y, Isobe M, et al. P-selectin expression, but not GPIIb/IIIa activation, is enhanced in the infammatory stage of Takayasu's arteritis. Circ J. 2006;70(5):600-604.
11. Nityanand S, Giscombe R, Srivastava S, et al. A bias in the alpha, beta-T-cell receptor variable region gene usage in Takayasu's arteritis. Clin Exp Immunol. 1997;107(2):261-268.
12. Dhawan V, Mahajan N, Jain S. Role of C-C chemokines in Takayasu's arteritis disease. Int J Cardiol. 2006;112(1):105-111.
13. Dhar J, Ganguly NK, Kumari S, Sharma BK. Role of calcium and protein kinase C in the activation of T cells in Takayasu's arteritis. Jpn Heart J. 1995;36(3):341-348.
14. Seko Y, Sato O, Takagi A, et al. Restricted usage of T-cell receptor Valpha-Vbeta genes in infltrating cells in aortic tissue of patients with Takayasu's arteritis. Circulation. 1996;93(10):1788-1790.
15. Seko Y. Giant cell and Takayasu arteritis. Curr Opin Rheumatol. 2007;19(1):39-43.
16. Noris M, Daina E, Gamba S, et al. Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions? Circulation. 1999;100(1):55-60.
17. Mahajan N, Dhawan V, Malik S, Jain S. Implication of oxidative stress and its correlation with activity of matrix metalloproteinases in patients with Takayasu's arteritis disease. Int J Cardiol. 2010;145(2):286-288.
18. Numano F, Kishi Y, Tanaka A, et al. Infammation and atherosclerosis: atherosclerosis lesions in Takayasu arteritis. Ann NY Acad Sci. 2000;902:65-76.
19. Seyahi E, Ugurlu S, Cumali R, et al. Atherosclerosis in Takayasu arteritis. Ann Rheum Dis. 2006;65(9):1202-1207.
20. de Souza AW, Ataíde Mariz H, Torres Reis Neto E, et al. Risk factors for cardiovascular disease and endothelin-1 levels in Takayasu arteritis patients. Clin Rheumatol. 2009;28(4):379-383.
21. Isohisa I, Numano F, Maezawa H, Sasazuki T. HLA-Bw52 in Takayasu disease. Tissue Antigens. 1978;12(4):246-248.
22. Park MH, Park YB. HLA typing of Takayasu arteritis in Korea. Heart Vessels Suppl. 1992;7:81-84.
23. Kitamura H, Kobayashi Y, Kimura A, Numano F. Association of clinical manifestations with HLA-B alleles in Takayasu arteritis. Int J Cardiol. 1998;66(Suppl 1):S121-S126.
24. Soto ME, Vargas-Alarcón G, Cicero-Sabido R, et al. Comparison distribution of HLA-B alleles in Mexican patients with Takayasu arteritis and tuberculosis. Hum Immunol. 2007;68(5):449-453.
25. Khraishi MM, Gladman DD, Dagenais P, et al. HLA antigens in North American patients with Takayasu arteritis. Arthritis Rheum. 1992;35(5):573-575.
26. Numano F, Ohta N, Sasazuki T. HLA and clinical manifestations in Takayasu disease. Jpn Circ J. 1982;46(2):184-189.
27. Kasuya K, Hashimoto Y, Numano F. Left ventricular dysfunction and HLA Bw52 antigen in Takayasu arteritis. Heart Vessels Suppl. 1992;7:116-119.
28. Saruhan-Direskeneli G, Biçakçigil M, Yilmaz V, et al. Interleukin (IL)-12, IL-2, and IL-6 gene polymorphisms in Takayasu's arteritis from Turkey. Hum Immunol. 2006;67(9):735-740.
29. Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J Clin Pathol. 2002;55(7):481-486.
30. Ueno A, Awane Y, Wakabayachi A, Shimizu K. Successfully operated obliterative brachiocephalic ar-teritis (Takayasu) associated with the elongated coarctation. Jpn Heart J. l967;8(5):538-544.
31. Lupi-Herrera E, Sánchez-Torres G, Marcushamer J, et al. Takayasu arteritis. Clinical study of 107 cases. Am Heart J. 1977;93(1):94-103.
32. Hata A, Noda M, Moriwaki R, Numano F. Angiographic fndings of Takayasu arteritis: new classifca-tion. Int J Cardiol. 1996;54(Suppl):S155-S163.
33. Cong XL, Dai SM, Feng X, et al. Takayasu's arteritis: clinical features and outcomes of 125 patients in China. Clin Rheumatol. 2010;29(9):973-981.
34. Gotway MB, Araoz PA, Macedo TA, et al. Imaging fndings in Takayasu's arteritis. AJR Am J Roentgenol. 2005;184(6):1945-1950.
35. Mavrogeni S, Dimitroulas T, Chatziioannou SN, Kitas G. Te role of multimodality imaging in the evaluation of Takayasu arteritis. Semin Arthritis Rheum. 2012. [Epub ahead of print].
36. Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med. 1994;120(11):919-929.
37. Tezuka D, Haraguchi G, Ishihara T, et al. Role of FDG PET-CTinTakayasu arteritis: sensitive detection of recurrences. JACC Cardiovasc Imaging. 2012;5(4):422-429.
38. Maksimowicz-Mckinnon K, Clark TM, Hofman GS. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum. 2007;56(3):1000-1009.
39. Hofman GS, Merkel PA, Brasington RD, et al. Anti-tumor necrosis factor therapy in patients with difcult to treat Takayasu arteritis. Arthritis Rheum. 2004;50(7):2296-2304.
40. Hofman GS, Ahmed AE. Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from the international network for the study of thesystemic vasculitides (INSSYS). Int J Cardiol. 1998;66(Suppl 1):S191-S194.
41. Matsuyama A, Sakai N, Ishigami M, et al. Matrix metalloproteinases as novel disease markers in Takayasu arteritis. Circulation. 2003;108(12):1469- 1473.
42. Sharma BK, Jain S, Bali HK, et al. A follow-up study of balloon angioplasty and de-novo stenting in Takayasu arteritis. Int J Cardiol. 2000;75(Suppl 1):S147-S152.
43. Andrews J, Mason JC. Takayasu's arteritis-recent advances in imaging ofer promise. Rheumatology. 2007;46(1):6-15.
44. Villa I, Agudo Bilbao M, Martínez-Taboada VM. Advances in the diagnosis of large vessel vasculitis: identifcation of biomarkers and imaging studies. Reumatol Clin. 2011;60((Suppl 3)): S22-S27.
45. Borg FA, Dasgupta B. Treatment and outcomes of large vessel arteritis. Best Pract Res Clin Rheumatol. 2009;23(3):325-337.
46. Pipitone N, Versari A, Salvarani C. Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology. 2008;47(4):403-408.
47. Chung JW, Kim HC, Choi YH, et al. Patterns of aortic involvement in Takayasu arteritis and its clinical implications: evaluation with spiral computed tomography angiography. J Vasc Surg. 2007;45(5):906-914.
48. Desai MY, Stone JH, Foo TK, et al. Delayed contrast-enhanced MRI of the aortic wall in takayasu's arteritis: initial experience. AJR Am J Roentgenol. 2005;184(5):1427-1431.
49. Kissin EY, Merkel PA. Diagnostic imaging in takayasu arteritis. Curr Opin Rheum. 2004;16(1):31-37.
50. Schmidt WA, BlockmansD. Use of ultrasonography and position emission tomography in the diagnosis of large-vessel vasculitis. Curr Opin Rheumatol. 2005;17(1):9-15.
51. Steeds RP, Mohiaddin R. Takayasu arteritis: role of cardiovascular magnetic imaging. Int J Cardiol. 2006;109(1):1-6.
52. Andrews J, Al-Nahhas A, Pennell DJ, et al. Non-invasive imaging in the diagnosis and management of Takayasu's arteritis. Ann Rheum Dis. 2004;63(8):995-1000.
53. Meller J, Grabbe E, Becker W, Vosshenrich R. Value of F-18 FDG hybrid camera PET and MRI in early Takayasu arteritis. Eur Radiol. 2003;13(2):400-405.
54. Tatsumi M, Cohade C, Nakamoto Y, Wahl RL. Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible fnding for active atherosclerosis. Radiology. 2003;229(3):831-837.
55. Umekita K, Takajo I, Miyauchi S, et al. [18F]fuorodeoxyglucose positron emission tomography is a useful tool to diagnose the early stage of Takayasu's arteritis and to evaluate the activity of the disease. Mod Rheumatol. 2006;16(4):243-247.
56. Arend WP, Michel BA, Bloch DA, et al. Te American college of rheumatology 1990 criteria for the classifcation of Takayasu arteritis. Arthritis Rheum. 1990;33(8):1129-1134.
57. Sharma BK, Jain S, Suri S, Numano F. Diagnostic criteria for Takayasu arteritis. Int J Cardiol. 1996;54(Suppl):S141-S147.
58. Sharma S, Saxena A, Talwar KK, et al. Renal artery stenosis caused by nonspecifc arteritis (Takayasu disease): results of treatment with percutaneous transluminal angioplasty. AJR Am J Roentgenol. 1992;158(2):417-422.
59. Seibel S, Gaa J, Küchle C, Frank H. Severe renovascular hypertension in apatient with Takayasu arteritis. Am J Kidney Dis. 2010;56(3):595-598.
60. Yun M, Yeh D, Araujo LI, et al. F-18 FDG uptake in the large arteries: a new observation. Clin Nucl Med. 2001;26:314-319.
61. Mafei S, Di Renzo M, Santoro S, et al. Refractory Takayasu arteritis successfully treated with infiximab. Eur Rev Med Pharmacol Sci. 2009;13(1):63-65.
62. Nunes G, Neves FS, Melo FM, et al. Takayasu arteritis: anti-TNF therapy in a Brazilian setting. Rev Bras Reumatol. 2010;50(3):291-298.
63. Saxena A, Kothari SS, Sharma S, et al. Percutaneous transluminal angioplasty of the aorta in children with nonspecifc aortoarteritis: acute and follow-up results with special emphasis on left ventricular function. Catheter Cardiovasc Interv. 2000;49(4):419-424.
64. Fields CE, Bower TC, Cooper LT, et al. Takayasu's arteritis: operative results and infuence of disease activity. J Vasc Surg. 2006;43(1):64-71.
65. Liang P, Hofman GS. Advances in the medical and surgical treatment of Takayasu arteritis. Curr Opin Rheumatol. 2005;17(1):16-24.
66. Ishikawa K, Maetani S. Long-term outcome for 120 Japanese patients with Takayasu's disease. Clinical and statistical analyses of related prognostic factors. Circulation. 1994;90(4):1855-1860.
67. Miyata T, Sato O, Koyama H, et al. Long-term survival after surgical treatment of patients with Takayasu's arteritis. Circulation. 2003;108(12):1474-1480.
68. Endo M, Tomizawa Y, Nishida H, et al. Angiographic fndings and surgical treatments of coronary artery involvement in Takayasu arteritis. JTorac Cardiovasc Surg. 2003;125(3):570-577.
69. Novick AC, Ziegelbaum M, Vidt DG, et al. Trends in surgical revascularization for renal artery disease. Ten years' experience. JAMA. 1987;257(4):498-501.
70. Miller GA, Ford KK, Braun SD, et al. Percutaneous transluminal angioplasty vs. surgery for renovascular hypertension. Am J Roentgenol. 1985;144(3):447-450.
71. Subramanyan R, Joy J, Balakrishnan KG. Natural history of aortoarteritis (Takayasu's disease). Circulation. 1989;80(3):429-437.
72. Freitas DS, Camargo CZ, Mariz HA, et al. Takayasu arteritis: assessment of response to medical therapy based on clinical activity criteria and imaging techniques. Rheumatol Int. 2012;32(3):703-709.
73. Park MC, Lee SW, Park YB, et al. Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classifcation. Scand J Rheumatol. 2005;34(4):284-292.